Why Big Pharma Won't Get Its Piece Of The $1.2 Trillion Global Drug Market |
| Forbes - Jul 12, 2012 |
The global market for prescription drugs will grow from $950 billion now to $1.2 trillion in 2016, according to a new report released today. But Big Pharma may sit out much of the growth as patents on big-selling drugs expire and people fast-growing markets such as China, Russia, and Brazil buy generic drugs from local manufacturers.
That’s the forecast from the IMS Institute for Healthcare Informatics, a unit of health information company IMS Health, which tracks prescription data and provides consulting services to drug makers and to Wall Street. The full report can be found at its web site, http://www.theimsinstitute.org. Here’s a quick swim through some of the key points. All the charts are from this report, which serves as not only a forecast but as an annual opportunity to take the drug industry’s temperature.
Read Full Article from Forbes
- Posted: 2012-07-12 13:56:18
| More Stock Investor Place Top Stories |
 |
|
|
|
| Stock Investor Place Top Stories Archive |
|
|
|
